Clinical Trials Logo

Clinical Trial Summary

The purpose of this investigation is to determine the effects of exercise training on quality of life and physical capacity, 3 months and 1 year after radical operation for pulmonary cancer.


Clinical Trial Description

Patients who are radically operated for pulmonary cancer report suffering from respiratory problems, mostly dyspnoea, 5 years after operation. Dyspnoea restricts their physical capability and leads to poorer physical, social and mental wellbeing. The effects of training programs on physical and mental wellbeing for cancer patients are well documented. Most of the studies are though performed on patients suffering from breast, colon and prostate cancer. There are only few studies addressing patients with pulmonary cancer. They are mostly focused on short term effects of exercise training on quality of life, with no control group included in the trials. These studies target patients after different forms for treatment, including surgery, chemotherapy and radiation. There is no data referring to quality of life of patients who are radically operated for pulmonary cancer.

Comparison: multidisciplinary group intervention consisting of exercise training and dyspnoea counseling, 10 times, once a week, compared with one instruction in exercise training and dyspnoea counseling. Exercise training is given by a physiotherapist. Both groups receive in addition standard treatment, which is up to 3 counseling sessions with a nurse. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01048762
Study type Interventional
Source Aalborg Universitetshospital
Contact
Status Completed
Phase Phase 2
Start date February 2006
Completion date September 2010

See also
  Status Clinical Trial Phase
Recruiting NCT03144622 - 18F-FSPG PET/CT Imaging in Patients With Cancers
Completed NCT01860898 - A Phase I Study of iPS Cell Generation From Patients With COPD N/A
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00098085 - Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer Phase 2
Completed NCT05011890 - Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® N/A
Completed NCT02616211 - An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Completed NCT03293433 - Quantification of microRNAs in Diagnosis of Pulmonary Nodules
Recruiting NCT05545085 - Thoracoscopic Laser Speckle Contrast Imaging for Segment Resections
Enrolling by invitation NCT06102369 - The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer
Completed NCT00344773 - First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation Phase 2
Not yet recruiting NCT05781581 - A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
Terminated NCT02673021 - MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) N/A
Not yet recruiting NCT05857995 - Precision Lung Cancer Survivorship Care Intervention N/A
Recruiting NCT05521789 - Erector Spinae Block for Thoracic Surgery Phase 4
Recruiting NCT04699188 - Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation Phase 1/Phase 2
Recruiting NCT05977803 - Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin N/A
Not yet recruiting NCT05694949 - Main Postoperative Complications After COVID-19
Completed NCT05915221 - Effect of SMS Use on Postoperative Respiratory and Cough Exercise Compliance N/A
Active, not recruiting NCT04740047 - Cios Mobile 3D Spin for Robotic Bronchoscopy
Completed NCT02410603 - Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer